Relevant Ongoing Clinical Trials to Investigate Local-Regional Treatment Strategies for Peritoneal Surface Malignancies.

IF 2 3区医学 Q3 ONCOLOGY

Journal of Surgical Oncology Pub Date : 2024-11-03 DOI:10.1002/jso.27853

S Blaj, S Häusler, P Piso

引用次数: 0

Abstract

Background and objectives: The multimodal therapy of peritoneal metastases of common cancers (i.e. colorectal, gastric, and ovarian), including CRS plus HIPEC, is still subject to several clinical studies.

Methods: This paper presents the ongoing studies regarding HIPEC, as found on clinicaltrials.gov. The emphasis was set on Phase III recruiting trials, including the newest information from principal investigators who answered the call of the authors.

Results: Ninety trials have been identified, and the protocols of 15 studies have been presented in detail.

Conclusions: There are interesting ongoing trials investigating the role of CRS plus HIPEC.

查看原文本刊更多论文

调查腹膜表面恶性肿瘤局部区域治疗策略的相关现行临床试验。

背景和目的：常见癌症（如结直肠癌、胃癌和卵巢癌）腹膜转移的多模式治疗，包括 CRS 加 HIPEC，仍在进行多项临床研究：本文介绍了临床试验网（clinicaltrials.gov）上正在进行的有关 HIPEC 的研究。方法：本文介绍了临床试验网（clinicaltrials.gov）上正在进行的有关 HIPEC 的研究，重点是 III 期招募试验，包括响应作者号召的主要研究者提供的最新信息：结果：确定了 90 项试验，并详细介绍了 15 项研究的方案：结论：目前正在进行一些有趣的试验，研究 CRS 加 HIPEC 的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Surgical Oncology 医学-外科

CiteScore

4.70

自引率

4.00%

发文量

367

审稿时长

2 months

期刊介绍： The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.